We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr Gets License For Generic Actiq As FTC Clears Cephalon-Cima Merger

Law360 (August 11, 2004, 12:00 AM EDT) -- Cephalon Inc. has granted Barr Laboratories Inc. a license to create a generic version of the pain killer Actiq as part of a deal with antitrust authorities to clear the drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.